Tromp Medical, Europe’s largest independent medical imaging sales and service organization, has attracted Gilde Healthcare as new investor to drive further growth in the medical imaging market. Headquartered in the Netherlands, Tromp Medical specializes in installing and maintaining various medical imaging equipment modalities such as mammography, CT, MRI and ultrasound systems from leading, highly innovative manufacturers, including Canon Medical Systems, Carestream, Hologic and Ziehm Imaging.
Since Dutch investor Capital A acquired a majority stake in the company in 2019, Tromp Medical has experienced significant growth, including expansions into France and Spain, and through the acquisition of Aura Medical in the Czech Republic in 2023.
Adding Gilde Healthcare marks a new growth phase, enabling the company to accelerate international growth through M&A and further expand its proven sales and service model in newly entered markets.
Konrad Eichberger, CEO of Tromp Medical commented: “We are delighted to welcome Gilde Healthcare as a key investor to the Tromp Medical group. This investment alongside Capital A represents a pivotal moment in our company’s evolution. Gilde Healthcare’s proven expertise and visionary approach will be instrumental as we push the boundaries of innovation and expand our impact in the Medical imaging market. Together, we will amplify our capabilities and accelerate our growth trajectory to achieve even greater success by delivering better images, thus better care to our patients.”
Raymond Kuijten, Partner at Capital A commented: “During past years we supported management to increase the geographical presence of Tromp Medical and in creating substantial growth. We welcome Gilde Healthcare as new investor in Tromp Medical for the next phase of growth of the company together with the management team.”
“We are very excited to invest in Tromp Medical, a trusted partner for healthcare providers in the medical imaging equipment market, with an impressive footprint of 7,000+ systems installed. These systems are essential in in the early detection of life threatening diseases, enabling faster treatment, improving health outcomes, and ultimately delivering better care at lower cost. We look forward to applying our deep sector knowledge to support Tromp Medical in its new growth phase,” said Hugo de Bruin, Partner at Gilde Healthcare.
About Capital A
Capital A is one of the most active private equity investors in the Netherlands, with a focus on supporting fast growing companies, both organically and acquisitively. Capital A became independent in 2018 in a spin-out from ABN AMRO Bank with the support of a mix of institutional investors, various entrepreneurs and the Capital A team itself. From offices in Amsterdam, Antwerp and Frankfurt, Capital A manages approximately €1 billion in invested capital, supporting a group of approximately 40 growth companies, mainly active in Europe in healthcare, business services or TMT.
About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €2.6 billion across two fund strategies: Venture&Growth and Private Equity. The Venture&Growth fund of Gilde Healthcare invests in fast growing companies active in digital health, medtech and therapeutics, based in Europe and North America. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. For more information, visit the company’s website at www.gildehealthcare.com.
Completion of the transaction is subject to regulatory approval.
